U.S. Court of Appeals for the Federal Circuit, 2012

Takeda Pharmaceuticals Co. Ltd. v. Zydus Pharmaceuticals Usa, Inc.

Takeda Pharmaceuticals Co. Ltd. v. Zydus Pharmaceuticals Usa, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided December 7, 2012

Takeda Pharmaceuticals Co. Ltd. v. Zydus Pharmaceuticals Usa, Inc.

Opinion

Case: 13-1089 Document: 9 Page: 1 Filed: 12/07/2012

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit __________________________ TAKEDA PHARMACEUTICALS COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS, LLC, TAKEDA PHARMACEUTICALS AMERICA, INC., AND ETHYPHARM, S.A., Plaintiffs-Appellees, v. ZYDUS PHARMACEUTICALS USA, INC. AND CADILA HEALTHCARE, LIMITED, Defendants-Appellants. __________________________ 2013-1089 __________________________ Appeal from the United States District Court for the District of New Jersey in case no. 10-CV-1723, Judge Joel A. Pisano. __________________________ ON MOTION __________________________ ORDER The appellants move to expedite briefing and argu- ment.

Upon consideration thereof, Case: 13-1089 Document: 9 Page: 2 Filed: 12/07/2012

TAKEDA PHARMACEUTICALS CO. V. ZYDUS PHARMACEUTICALS 2 USA IT IS ORDERED THAT: (1) The motion to expedite briefing is granted to the following extent: The appellants' opening brief is due December 17. The appellees' brief is due January 2, 2013.

The appellants' reply brief and the joint appendix are due January 9, 2013. (2) Oral argument will be scheduled by subsequent order of the court.

FOR THE COURT

/s/ Jan Horbaly Jan Horbaly Clerk s8

Case-law data current through December 31, 2025. Source: CourtListener bulk data.